MARKET

PERCF

PERCF

Percheron Therapeutics
OTCPK
0.0050
NaN%
Closed 09:30 02/09 EST
OPEN
--
PREV CLOSE
0.0050
HIGH
--
LOW
--
VOLUME
--
TURNOVER
--
52 WEEK HIGH
0.010
52 WEEK LOW
0.0021
MARKET CAP
5.44M
P/E (TTM)
-0.5208
1D
5D
1M
3M
1Y
5Y
1D
Percheron Advances HMBD-002 into Innovative Phase II After Positive Phase I Cancer Data
TipRanks · 01/30 00:09
Percheron Therapeutics Director Increases On-Market Shareholding
TipRanks · 12/29/2025 22:35
Percheron Therapeutics Director James Garner Increases Shareholding via On-Market Purchase
TipRanks · 12/23/2025 00:18
Percheron Therapeutics Updates Corporate Presentation with New Program Insights
TipRanks · 11/04/2025 22:55
Percheron Therapeutics Advances HMBD-002 with Positive Trial Results
TipRanks · 10/31/2025 00:17
Percheron Therapeutics Reports Strong Shareholder Support at AGM
TipRanks · 10/22/2025 03:28
Percheron Therapeutics Unveils Future Plans at AGM
TipRanks · 10/22/2025 01:28
Percheron Therapeutics Releases Final Results of Phase I Clinical Trial for HMBD-002
Barchart · 10/07/2025 17:20
More
About PERCF
Percheron Therapeutics Limited is an Australia-based biotechnology company. The Company is focused on the development and commercialization of novel therapies for oncology and rare diseases. The Company’s lead program is HMBD-002, a monoclonal antibody targeting the immune checkpoint regulator, VISTA. HMBD-002 has completed a phase I clinical trial in patients with advanced cancer. HMBD-002 is a recombinant humanized monoclonal IgG4 antibody to human v-domain immunoglobulin suppressor of T-cell activation (VISTA). VISTA is one of a number of novel immuno-oncology targets under investigation by pharmaceutical companies, with potential applications to a range of solid tumors and hematological malignancies.

Webull offers Percheron Therapeutics Ltd stock information, including OTCPK: PERCF real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, PERCF stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading PERCF stock methods without spending real money on the virtual paper trading platform.